Procardia xl and Neutrophil count decreased - a phase IV clinical study of FDA data

Summary:

Neutrophil count decreased is reported only by a few people who take Procardia Xl.

The phase IV clinical study analyzes which people take Procardia xl and have Neutrophil count decreased. It is created by eHealthMe based on reports of 5,977 people who have side effects while taking Procardia xl from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 15, 2022

5,977 people reported to have side effects when taking Procardia xl.
Among them, 2 people (0.03%) have Neutrophil count decreased.


What is Procardia xl?

Procardia xl has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 6,135 Procardia xl users for its effectiveness, alternative drugs and more.

What is Neutrophil count decreased?

Neutrophil count decreased (less than normal number of neutrophil a type of blood cell) is found to be associated with 1,841 drugs and 1,593 conditions by eHealthMe.

Number of Procardia xl and Neutrophil count decreased reports submitted per year:

Could Procardia xl cause Neutrophil count decreased?

Gender of people who have Neutrophil count decreased when taking Procardia xl *:

  • female: 50 %
  • male: 50 %

Age of people who have Neutrophil count decreased when taking Procardia xl *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Procardia xl *:

  1. Valtrex: 1 person, 50.00%
  2. Norfloxacin: 1 person, 50.00%
  3. Lopressor: 1 person, 50.00%
  4. Exjade: 1 person, 50.00%
  5. Dyazide: 1 person, 50.00%

Common side effects people have besides Neutrophil count decreased *:

  1. Oedema Peripheral (superficial swelling): 2 people, 100.00%
  2. Crepitations (noises are produced by the rubbing of parts one against the other): 1 person, 50.00%
  3. Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 1 person, 50.00%
  4. Fever: 1 person, 50.00%
  5. Febrile Neutropenia (fever with reduced white blood cells): 1 person, 50.00%
  6. Ejection Fraction Decreased (systolic heart failure): 1 person, 50.00%
  7. Disease Progression: 1 person, 50.00%
  8. Diastolic Dysfunction: 1 person, 50.00%
  9. White Blood Cell Count Decreased: 1 person, 50.00%
  10. Mouth Ulcers: 1 person, 50.00%

Common conditions people have *:

  1. Iron Overload: 1 person, 50.00%
  2. Breast Cancer: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Procardia xl and have Neutrophil count decreased?

Check whether Neutrophil count decreased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Neutrophil count decreased and when was it recovered:

Expand to all the drugs that have ingredients of nifedipine:

Alternative drugs to, pros and cons of Procardia xl:

Common Procardia xl side effects:

Browse all side effects of Procardia xl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Neutrophil count decreased treatments and more:

COVID vaccines that are related to Neutrophil count decreased:

Common drugs associated with Neutrophil count decreased:

All the drugs that are associated with Neutrophil count decreased:

Common conditions associated with Neutrophil count decreased:

All the conditions that are associated with Neutrophil count decreased:

How the study uses the data?

The study uses data from the FDA. It is based on nifedipine (the active ingredients of Procardia xl) and Procardia xl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: